Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication April 25, 2021
- Revision received August 5, 2021
- Published online April 28, 2022.
Article Versions
- previous version (August 19, 2021 - 09:49).
- previous version (January 6, 2022 - 13:04).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Michael D. Farwell1,2,
- Raymond F. Gamache1,
- Hasan Babazada1,
- Matthew D. Hellmann3,4,5,
- James J. Harding4,5,
- Ron Korn6,
- Alessandro Mascioni7,
- William Le7,
- Ian Wilson7,
- Michael S. Gordon8,
- Anna M. Wu7,9,
- Gary A. Ulaner10,
- Jedd D. Wolchok3,4,5,11,
- Michael A. Postow*,4,5 and
- Neeta Pandit-Taskar*,3,12,13
- 1Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania;
- 2Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania;
- 3Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York;
- 4Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York;
- 5Department of Medicine, Weill Cornell Medical College, New York, New York;
- 6Imaging Endpoints, Scottsdale, Arizona;
- 7ImaginAb, Inc., Inglewood, California;
- 8HonorHealth Research Institute, Scottsdale, Arizona;
- 9Department of Molecular Imaging and Therapy, Beckman Research Institute of the City of Hope, Duarte, California;
- 10Molecular Imaging and Therapy, Hoag Family Cancer Institute, Newport Beach, California;
- 11Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York;
- 12Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and
- 13Department of Radiology, Weill Cornell Medical College, New York, New York
- For correspondence or reprints, contact Michael D. Farwell (michael.farwell{at}pennmedicine.upenn.edu).
↵* Contributed equally to this work.
Statistics from Altmetric.com
Article usage
In this issue
CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of 89Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody
Jump to section
Related Articles
Cited By...
- No citing articles found.